New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases-Reference-Cited by-同舟云学术

New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases

Published:2021-01 Issue: Volume:209 Page:112854
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Ručilová Veronika,Świerczek Artur,Vanda David,Funk Petr,Lemrová Barbora,Gawalska Alicja,Bucki Adam^ORCID,Nowak Barbara,Zadrożna Monika,Pociecha Krzysztof,Soural Miroslav,Wyska Elżbieta,Pawłowski Maciej,Chłoń-Rzepa Grażyna,Zajdel Paweł^ORCID

Funder

Narodowym Centrum Nauki

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference41 articles.

1. Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases;Li;Front. Pharmacol.,2018

2. Phosphodiesterase 4 inhibitors in immune-mediated diseases: mode of action, clinical applications, current and future perspectives;Sakkas;Curr. Med. Chem.,2017

3. Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis;Robichaud;J. Clin. Invest.,2002

4. An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease;Giembycz;Br. J. Clin. Pharmacol.,2006

5. Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety;Burgin;Nat. Biotechnol.,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases;European Journal of Medicinal Chemistry;2024-05

2. Glycogen Synthase Kinase-3β Inhibitor VP3.15 Ameliorates Neurogenesis, Neuronal Loss and Cognitive Impairment in a Model of Germinal Matrix-intraventricular Hemorrhage of the Preterm Newborn;Translational Stroke Research;2024-01-17

3. Xanthine–Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases;Biomolecules;2023-07-05

4. PDE4 inhibitors for disease therapy: advances and future perspective;Future Medicinal Chemistry;2023-07

5. I2/DTBP Promoted Synthesis of C3-Carbonylated Imidazopyridines from Chromones and 2-Aminopyridines via (3+2) Cycloaddition;Synthesis;2023-03-20